InspireMD Inc. (NSPR)

06:13 AM

Investors in InspireMD (NASDAQ:NSPR) from five years ago are still down 86%, even after 10% gain this past week - Simply Wall St

06:13 AM

Jan 21, 2025

InspireMD Announces Inducement Grants Under Nasdaq Listing Rule 5635(c)(4) - GlobeNewswire

Jan 21, 2025

Jan 21, 2025

Compliance Issues And Stock Developments Hit Nasdaq Companies - Evrim Ağacı

Jan 21, 2025

Jan 21, 2025

InspireMD (NYSE:NSPR) Now Covered by Analysts at StockNews.com - MarketBeat

Jan 21, 2025

Jan 21, 2025

StockNews.com Initiates Coverage on InspireMD (NYSE:NSPR) - Defense World

Jan 21, 2025

Jan 20, 2025

InspireMD : Breakthrough device in clinical trials aims to prevent strokes -January 20, 2025 at 07:59 am EST - Marketscreener.com

Jan 20, 2025

Jan 14, 2025

Here's Why We're Watching InspireMD's (NASDAQ:NSPR) Cash Burn Situation - Yahoo Finance

Jan 14, 2025

Jan 13, 2025

InspireMD (NYSE:NSPR) Coverage Initiated by Analysts at StockNews.com - MarketBeat

Jan 13, 2025

Jan 13, 2025

InspireMD (NYSE:NSPR) Now Covered by StockNews.com - Defense World

Jan 13, 2025

Jan 05, 2025

StockNews.com Begins Coverage on InspireMD (NYSE:NSPR) - Defense World

Jan 05, 2025

Dec 20, 2024

InspireMD (NYSE:NSPR) Earns Sell Rating from Analysts at StockNews.com - MarketBeat

Dec 20, 2024

Dec 14, 2024

InspireMD, Inc. CFO Craig Shore to Retire, Company Initiates Search for SuccessorDecember 12, 2024 - Defense World

Dec 14, 2024

Dec 12, 2024

NSPRInspireMD, Inc. Latest Stock News & Market Updates - StockTitan

Dec 12, 2024

Dec 12, 2024

Medical device company kicks off search for next CFO - The Business Journals

Dec 12, 2024

Dec 12, 2024

InspireMD CFO Craig Shore to retire, successor search underway - Investing.com India

Dec 12, 2024

Dec 12, 2024

InspireMD CFO Retirement Amid Strategic Transition - TipRanks

Dec 12, 2024

Dec 12, 2024

InspireMD Announces Expected Retirement of its CFO Craig Shore and CFO Transition in 2025 - GlobeNewswire

Dec 12, 2024

Dec 12, 2024

InspireMD CFO to Retire After 15 Years Amid Crucial FDA Approval Timeline for Stroke Prevention Device - StockTitan

Dec 12, 2024

Dec 12, 2024

NSPR Stock May Gain as First Patient Enrolls in CGUARDIANS II Study - MSN

Dec 12, 2024

Dec 12, 2024

Lake Street Initiates Coverage of InspireMD (NSPR) with Buy Recommendation - MSN

Dec 12, 2024

Dec 11, 2024

InspireMD Announces First Patient Enrolled in CGUARDIANS II Pivotal Study - Defense World

Dec 11, 2024

Dec 10, 2024

Inspiremd Announces First Patient Enrolled in the Cguardians Ii Pivotal Study of the Cguard Prime Carotid Stent System in Transcarotid Artery Revascularization Procedures - Marketscreener.com

Dec 10, 2024

Dec 09, 2024

InspireMD Advances CGuard Prime with New Clinical Trial - TipRanks

Dec 09, 2024

Dec 09, 2024

InspireMD Announces First Patient Enrolled in the CGUARDIANS II Pivotal Study of the CGuard Prime Carotid Stent System in Transcarotid Artery Revascularization Procedures (TCAR) - GlobeNewswire

Dec 09, 2024

Dec 09, 2024

InspireMD Launches Pivotal CGUARDIANS II Trial for Revolutionary Carotid Stent System - StockTitan

Dec 09, 2024

Dec 01, 2024

Head to Head Contrast: Penumbra (NYSE:PEN) vs. InspireMD (NYSE:NSPR) - Defense World

Dec 01, 2024

Nov 26, 2024

InspireMD adds medtech veteran Scott Ward to its board By Investing.com - Investing.com South Africa

Nov 26, 2024

Nov 26, 2024

InspireMD (NYSE:NSPR) Coverage Initiated at StockNews.com - Defense World

Nov 26, 2024

Nov 26, 2024

InspireMD appoints Scott R. Ward to its Board - Medical Buyer

Nov 26, 2024

Nov 26, 2024

InspireMD Appoints Scott R. Ward to Board of Directors - Defense World

Nov 26, 2024

Nov 25, 2024

InspireMD, Inc. Appoints Scott R. Ward to Its Board of Directors - Marketscreener.com

Nov 25, 2024

Nov 25, 2024

InspireMD adds medtech veteran Scott Ward to its board - Investing.com

Nov 25, 2024

Nov 25, 2024

InspireMD Strengthens Leadership with Scott R. Ward Appointment - TipRanks

Nov 25, 2024

Nov 25, 2024

InspireMD Announces Appointment of Accomplished Medical - GlobeNewswire

Nov 25, 2024

Nov 25, 2024

InspireMD Strengthens Board with Ex-Medtronic Executive Ahead of CGuard Prime FDA Decision | NSPR Stock News - StockTitan

Nov 25, 2024

Nov 15, 2024

InspireMD Third Quarter 2024 Earnings: US$0.16 loss per share (vs US$0.15 loss in 3Q 2023) - Simply Wall St

Nov 15, 2024

Nov 14, 2024

InspireMD, Inc. (NSPR) Reports Q3 Loss, Tops Revenue Estimates - MSN

Nov 14, 2024

Nov 14, 2024

InspireMD Inc (NSPR) Quarterly 10-Q Report - Quartzy

Nov 14, 2024

Nov 13, 2024

InspireMD, Inc. (NASDAQ:NSPR) Q3 2024 Earnings Call Transcript - Insider Monkey

Nov 13, 2024

Nov 13, 2024

InspireMD Inc. Faces Financial Uncertainty Amidst Ongoing Losses and Cash Flow Challenges - TipRanks

Nov 13, 2024

Nov 12, 2024

InspireMD Inc. Reports Q3 2024 Financial Results - TipRanks

Nov 12, 2024

Nov 12, 2024

InspireMD Achieves Record Q3 Revenue with CGuard Success - TipRanks

Nov 12, 2024

Nov 12, 2024

InspireMD Reports Third Quarter 2024 Financial Results and Provides Business Update - GlobeNewswire

Nov 12, 2024

Nov 12, 2024

InspireMD Sets Revenue Record, Files FDA Approval for CGuard Stent Amid Wider Losses | NSPR Stock News - StockTitan

Nov 12, 2024